Charles Schwab’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.24M | Buy |
164,647
+4,846
| +3% | +$36.6K | ﹤0.01% | 2830 |
|
|
2025
Q1 | $882K | Buy |
159,801
+4,974
| +3% | +$27.5K | ﹤0.01% | 2886 |
|
|
2024
Q4 | $890K | Sell |
154,827
-7,571
| -5% | -$43.5K | ﹤0.01% | 2955 |
|
|
2024
Q3 | $1.68M | Sell |
162,398
-1,649
| -1% | -$17.1K | ﹤0.01% | 2757 |
|
|
2024
Q2 | $2.13M | Buy |
164,047
+3,047
| +2% | +$39.5K | ﹤0.01% | 2688 |
|
|
2024
Q1 | $2.81M | Buy |
161,000
+13,669
| +9% | +$239K | ﹤0.01% | 2491 |
|
|
2023
Q4 | $1.39M | Sell |
147,331
-9,291
| -6% | -$87.4K | ﹤0.01% | 2724 |
|
|
2023
Q3 | $1.75M | Buy |
156,622
+4,965
| +3% | +$55.5K | ﹤0.01% | 2638 |
|
|
2023
Q2 | $3.25M | Buy |
151,657
+3,099
| +2% | +$66.3K | ﹤0.01% | 2394 |
|
|
2023
Q1 | $6.01M | Buy |
148,558
+2,668
| +2% | +$108K | ﹤0.01% | 2122 |
|
|
2022
Q4 | $6.79M | Buy |
145,890
+3,783
| +3% | +$176K | ﹤0.01% | 2046 |
|
|
2022
Q3 | $7.37M | Buy |
142,107
+7,876
| +6% | +$409K | ﹤0.01% | 2005 |
|
|
2022
Q2 | $6.35M | Sell |
134,231
-1,895
| -1% | -$89.6K | ﹤0.01% | 2082 |
|
|
2022
Q1 | $9.69M | Buy |
136,126
+6,863
| +5% | +$489K | ﹤0.01% | 1974 |
|
|
2021
Q4 | $9.67M | Buy |
129,263
+1,517
| +1% | +$113K | ﹤0.01% | 2021 |
|
|
2021
Q3 | $7.26M | Buy |
127,746
+1,015
| +0.8% | +$57.7K | ﹤0.01% | 2189 |
|
|
2021
Q2 | $5.58M | Buy |
126,731
+2,091
| +2% | +$92K | ﹤0.01% | 2298 |
|
|
2021
Q1 | $6.15M | Buy |
124,640
+3,908
| +3% | +$193K | ﹤0.01% | 2192 |
|
|
2020
Q4 | $5.08M | Buy |
120,732
+2,802
| +2% | +$118K | ﹤0.01% | 2202 |
|
|
2020
Q3 | $5.4M | Buy |
117,930
+3,074
| +3% | +$141K | ﹤0.01% | 2021 |
|
|
2020
Q2 | $5.77M | Buy |
114,856
+7,316
| +7% | +$367K | ﹤0.01% | 1958 |
|
|
2020
Q1 | $5.53M | Sell |
107,540
-1,479
| -1% | -$76.1K | ﹤0.01% | 1782 |
|
|
2019
Q4 | $6.74M | Buy |
109,019
+52
| +0% | +$3.21K | ﹤0.01% | 1866 |
|
|
2019
Q3 | $6.55M | Buy |
108,967
+2,826
| +3% | +$170K | ﹤0.01% | 1830 |
|
|
2019
Q2 | $8.96M | Buy |
106,141
+4,950
| +5% | +$418K | 0.01% | 1661 |
|
|
2019
Q1 | $9.67M | Buy |
101,191
+3,814
| +4% | +$364K | 0.01% | 1618 |
|
|
2018
Q4 | $6.9M | Sell |
97,377
-7,182
| -7% | -$509K | 0.01% | 1708 |
|
|
2018
Q3 | $8.94M | Buy |
104,559
+10,230
| +11% | +$874K | 0.01% | 1717 |
|
|
2018
Q2 | $10.9M | Buy |
94,329
+2,835
| +3% | +$329K | 0.01% | 1534 |
|
|
2018
Q1 | $7.4M | Sell |
91,494
-5,778
| -6% | -$468K | 0.01% | 1707 |
|
|
2017
Q4 | $5.71M | Buy |
97,272
+40,853
| +72% | +$2.4M | ﹤0.01% | 1864 |
|
|
2017
Q3 | $2.64M | Buy |
56,419
+2,803
| +5% | +$131K | ﹤0.01% | 2185 |
|
|
2017
Q2 | $1.93M | Buy |
53,616
+304
| +0.6% | +$10.9K | ﹤0.01% | 2232 |
|
|
2017
Q1 | $1.64M | Buy |
53,312
+2,736
| +5% | +$84.3K | ﹤0.01% | 2264 |
|
|
2016
Q4 | $1.7M | Buy |
50,576
+2,464
| +5% | +$82.6K | ﹤0.01% | 2244 |
|
|
2016
Q3 | $1.28M | Sell |
48,112
-4,650
| -9% | -$124K | ﹤0.01% | 2326 |
|
|
2016
Q2 | $1.16M | Sell |
52,762
-73,126
| -58% | -$1.61M | ﹤0.01% | 2298 |
|
|
2016
Q1 | $3.7M | Sell |
125,888
-44,265
| -26% | -$1.3M | ﹤0.01% | 1699 |
|
|
2015
Q4 | $5.62M | Buy |
170,153
+5,513
| +3% | +$182K | 0.01% | 1439 |
|
|
2015
Q3 | $5.95M | Buy |
164,640
+44,716
| +37% | +$1.62M | 0.01% | 1360 |
|
|
2015
Q2 | $5.4M | Buy |
119,924
+45,228
| +61% | +$2.04M | 0.01% | 1504 |
|
|
2015
Q1 | $2.29M | Buy |
74,696
+3,874
| +5% | +$119K | ﹤0.01% | 1986 |
|
|
2014
Q4 | $3.6M | Buy |
70,822
+15,988
| +29% | +$813K | 0.01% | 1678 |
|
|
2014
Q3 | $2.17M | Buy |
54,834
+37,180
| +211% | +$1.47M | ﹤0.01% | 1925 |
|
|
2014
Q2 | $761K | Buy |
17,654
+9,852
| +126% | +$425K | ﹤0.01% | 2450 |
|
|
2014
Q1 | $313K | Buy |
7,802
+180
| +2% | +$7.22K | ﹤0.01% | 2783 |
|
|
2013
Q4 | $208K | Sell |
7,622
-9,284
| -55% | -$253K | ﹤0.01% | 2945 |
|
|
2013
Q3 | $401K | Buy |
+16,906
| New | +$401K | ﹤0.01% | 2631 |
|